When Paget's disease is diagnosed, referral to a specialist for assessment is recommended.

Specific anti-pagetic treatment involves the use of osteoclast inhibitors to reduce the elevation in bone turnover that is characteristic of active disease. In addition, analgesics, non-steroidal anti-inflammatory drugs, and anti-neuropathic pain agents can be used for symptom control.

When treatment is required, Bisphosphonates are used and Zoledronate is often the drug of choice as it acts quickly and can be effective for many years.

The main reason for treatment is if the affected bones are painful. If the pain is directly from Paget’s disease, it often improves with treatment. Pain, however, can arise from complications. The clinical benefit of giving bisphosphonates to patients who have a raised level of alkaline phosphatase in their blood, but do not have symptoms, is unknown. It can take several months for bisphosphonates to have their full effect and for the individual to feel the maximum benefit.

Alkaline Phosphatase (ALP) is an indicator of disease activity and should be measured prior to starting treatment and repeated about 3 months later when it should have decreased. It should be noted that Paget's disease can be active and yet the alkaline phosphatase (ALP) may remain within the normal range, particularly if the area involved is small.

Page to appear on: 

Receive the paget’s magazine

By becoming a member

Become a Friend of the Paget's Association

If you are not a member of the Association, but would like to stay up to date with our news and events via our mailing list, please sign up here to become a Friend of the Association. Please note, if you are a member, there's no need to sign up here as you already receive our updates and much more!

Your Details